Clinical Trial Update: A Phase 1 Study of LNCB74 in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Status update for a Phase 1 study of the investigational agent LNCB74 in patients with various advanced solid tumors, including ovarian, breast, endometrial, bi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Breast Cancer
• Endometrial Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer

Drugs mentioned

• LNCB74

Snippet

Sponsor: NextCure, Inc. | Conditions: Ovarian Cancer, Breast Cancer | Phase 1 | Status: RECRUITING